Purdue Sues KV Over OxyContin Patent

Law360, New York (June 11, 2007, 12:00 AM EDT) -- Less than two weeks after a Manhattan court entered a consent judgment that marked an end to a patent infringement battle over the painkiller OxyContin, OxyContin maker Purdue Pharma LP has filed a new lawsuit against KV Pharmaceutical Co. asserting three patents covering controlled-release oxycodone.

Wednesday, Purdue Pharma LP filed suit against KV Pharmaceutical in the U.S. District Court for the Southern District of New York, the same court in which Judge Sidney Stein approved a deal which resolved a long-running legal battle between Purdue Pharma...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.